GeneLink Q2 Revenues Retreat 35 Percent | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – GeneLink's revenues for the second quarter retreated 35 percent year over year, the company reported after the close of the market on Tuesday.

For the three months ended June 30, the Orlando, Fla.-based firm posted receipts of $1.3 million, down from $2 million a year ago, according to a document filed with the US Securities and Exchange Commission.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Researchers have found a new kind of virus — one that starts out broken up into five parts.

Nature News explores the president's "science legacy."

In PLOS this week: genetic factors associated with facial features, a new mutation that makes individuals more prone to Brugada syndrome, and more.

Nutrigenomic companies offer gene-based diet advice, the Wall Street Journal reports.